Questions to take · Care handbook
Bring questions. Leave with clear answers.
There is no prize for remembering every drug term. Take the questions that fit your situation, and ask for an answer in plain words.
Ask what the treatment is meant to change.
- What result are we trying to reach in my case?
- What makes tesamorelin a fit for that goal?
- Which study best supports that use in people like me?
- How will we tell whether it is helping?
The September 2026 approval covered extra belly fat linked to lipodystrophy in adults living with HIV.
HIV means human immunodeficiency virus; lipodystrophy is a shift in where the body stores fat.
A proposed use beyond that approved purpose is called off-label.
Look at the groups and results studiedAsk what is being prescribed.
- What is the full product name?
- Is the proposed product tesamorelin (EGRIFTA SV or EGRIFTA WR)?
- Which pharmacy would supply the medicine?
- How will I get instructions for this exact product from the prescriber or pharmacist?
The September 2026 label says EGRIFTA SV and EGRIFTA WR cannot be swapped for each other.
The two names are worth writing down in full.
For storage, follow the exact product’s label and pharmacy instructions; there is no shared storage rule for all peptides.
Used needles belong in a sharps container, a sturdy container for pointed medical waste, according to FDA (Food and Drug Administration) disposal advice.
Ask the care team to explain handling and disposal for the product you receive.
Ask about the checks, costs, and next conversation.
- Which tests are part of this plan, and who reviews them?
- What health history or other medicines could change the plan?
- Who can I reach if something unexpected happens?
- What is included in the quote, and what is extra?
- When will we review whether continuing makes sense?
The label asks for blood sugar tests and checks of IGF-1, a body signal that helps tissues grow. The medicine can raise IGF-1 far above normal, and the effects of staying that high are unknown.
If your sport follows rules from the World Anti-Doping Agency (WADA), tesamorelin is banned both during and outside competition (September 2026 list).
If those rules apply to you and you need tesamorelin for medical care, ask about special permission to use a banned medicine, called a therapeutic use exemption.
Ask the organisation that checks your sport’s drug rules whether you need this permission before treatment. A prescription alone does not give that permission.
Ask the organiser whether these rules apply to your competition, even if you do not compete professionally.
